CROCS INC
CROXNASDAQ🏆 #1191 by market capEarnings Oct 29 · PreUS Equity
$122.63▲ $0.27 (+0.22%)
Market closed · at closeTrack CROX
Get earnings, price moves & breaking news on Telegram
24h▲ 0.2%
7d▼ 1.5%
14d▲ 6.3%
30d▲ 1.9%
ytd▲ 43.5%
1y▲ 46.9%
🏦Market Cap
$5.88B
Small Cap
📈Revenue Growth (YoY)
-1.5%
Declining
📊Gross Margin
57.5%
Healthy
💵FCF Margin
17.4%
Healthy
⚖️P/S Ratio
1.4x
Cheap
Otter Score
72
Fair
CROCS INC
CROXAnalyst Ratings
Price
$122.63
Total
37
Raised
9
Lowered
7
Avg PT
$136.78
H / L
$163 / $95
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
UBS | Reiterated | Neutral | 2026-07-31 | $120.00 | −2.10% |
Barclays | Reiterated | Equal Weight | 2026-07-31 | $118.00 | −3.80% |
B of A Securities | Reiterated | Buy | 2026-07-23 | — | — |
Seaport Global | Reiterated | Buy | 2026-07-20 | $160.00 | +30.50% |
Piper Sandler | Upgraded | Neutral → Overweight | 2026-06-26 | $150.00 | +22.30% |
Stifel | Reiterated | Hold | 2026-06-15 | — | — |
Baird | Upgraded | Neutral → Outperform | 2026-06-08 | — | — |
Needham | Reiterated | Buy | 2026-04-21 | $150.00 | +22.30% |
Goldman Sachs | Reiterated | Sell | 2026-02-13 | $95.00 | −22.50% |
Keybanc | Downgraded | Overweight → Sector Weight | 2026-01-22 | $150.00 | +22.30% |
BWG Global | Upgraded | Negative → Mixed | 2026-01-08 | — | — |
Loop Capital | Reiterated | Buy | 2025-04-01 | — | — |
Guggenheim | Reiterated | Buy | 2025-02-03 | $155.00 | +26.40% |
Raymond James | Downgraded | Outperform → Market Perform | 2024-10-30 | — | — |
Williams Trading | Upgraded | Hold → Buy | 2024-08-22 | $150.00 | +22.30% |
Wedbush | Reiterated | Outperform | 2024-07-29 | $153.00 | +24.80% |
OTR Global | Upgraded | Mixed → Positive | 2024-04-11 | — | — |
B. Riley Securities | Reiterated | Neutral | 2024-04-10 | — | — |
Exane BNP Paribas | Reiterated | Neutral | 2022-09-21 | — | — |
Pivotal Research | Reiterated | Buy | 2021-07-20 | — | — |
B. Riley FBR | Upgraded | Neutral → Buy | 2020-08-25 | — | — |
CL King | Downgraded | Buy → Neutral | 2020-07-17 | — | — |
Susquehanna | Reiterated | Positive | 2020-04-06 | — | — |
Piper Jaffray | Reiterated | Overweight | 2019-10-08 | — | — |
Stifel Nicolaus | Downgraded | Buy → Hold | 2018-05-09 | $125.00 | +1.90% |
Buckingham Research | Reiterated | Underweight | 2018-03-01 | — | — |
Buckingham | Reiterated | Underweight | 2018-03-01 | — | — |
PiperJaffray | Upgraded | Neutral → Overweight | 2018-03-01 | — | — |
Monness, Crespi, Hardt | Downgraded | Buy → Neutral | 2016-11-10 | — | — |
Monness Crespi Hardt | Downgraded | Buy → Neutral | 2016-11-10 | — | — |
Sterne Agee | Upgraded | Neutral → Buy | 2016-05-10 | — | — |
Sterne Agee CRT | Upgraded | Neutral → Buy | 2016-05-10 | — | — |
Standpoint Research | Downgraded | Buy → Hold | 2015-05-04 | — | — |
Wunderlich | Reiterated | Buy | 2014-10-01 | — | — |
Imperial Capital | Reiterated | In Line | 2013-12-31 | — | — |
Benchmark | Reiterated | Buy | 2012-06-22 | — | — |
SunTrust Robinson Humphrey | Reiterated | Neutral | 2012-05-17 | — | — |
Institution
UBS
Reiterated · Neutral · 2026-07-31
$120.00
−2.10%
Barclays
Reiterated · Equal Weight · 2026-07-31
$118.00
−3.80%
B of A Securities
Reiterated · Buy · 2026-07-23
—
—
Seaport Global
Reiterated · Buy · 2026-07-20
$160.00
+30.50%
Piper Sandler
Upgraded · Neutral → Overweight · 2026-06-26
$150.00
+22.30%
Stifel
Reiterated · Hold · 2026-06-15
—
—
Baird
Upgraded · Neutral → Outperform · 2026-06-08
—
—
Needham
Reiterated · Buy · 2026-04-21
$150.00
+22.30%
Goldman Sachs
Reiterated · Sell · 2026-02-13
$95.00
−22.50%
Keybanc
Downgraded · Overweight → Sector Weight · 2026-01-22
$150.00
+22.30%
BWG Global
Upgraded · Negative → Mixed · 2026-01-08
—
—
Loop Capital
Reiterated · Buy · 2025-04-01
—
—
Guggenheim
Reiterated · Buy · 2025-02-03
$155.00
+26.40%
Raymond James
Downgraded · Outperform → Market Perform · 2024-10-30
—
—
Williams Trading
Upgraded · Hold → Buy · 2024-08-22
$150.00
+22.30%
Wedbush
Reiterated · Outperform · 2024-07-29
$153.00
+24.80%
OTR Global
Upgraded · Mixed → Positive · 2024-04-11
—
—
B. Riley Securities
Reiterated · Neutral · 2024-04-10
—
—
Exane BNP Paribas
Reiterated · Neutral · 2022-09-21
—
—
Pivotal Research
Reiterated · Buy · 2021-07-20
—
—
B. Riley FBR
Upgraded · Neutral → Buy · 2020-08-25
—
—
CL King
Downgraded · Buy → Neutral · 2020-07-17
—
—
Susquehanna
Reiterated · Positive · 2020-04-06
—
—
Piper Jaffray
Reiterated · Overweight · 2019-10-08
—
—
Stifel Nicolaus
Downgraded · Buy → Hold · 2018-05-09
$125.00
+1.90%
Buckingham Research
Reiterated · Underweight · 2018-03-01
—
—
Buckingham
Reiterated · Underweight · 2018-03-01
—
—
PiperJaffray
Upgraded · Neutral → Overweight · 2018-03-01
—
—
Monness, Crespi, Hardt
Downgraded · Buy → Neutral · 2016-11-10
—
—
Monness Crespi Hardt
Downgraded · Buy → Neutral · 2016-11-10
—
—
Sterne Agee
Upgraded · Neutral → Buy · 2016-05-10
—
—
Sterne Agee CRT
Upgraded · Neutral → Buy · 2016-05-10
—
—
Standpoint Research
Downgraded · Buy → Hold · 2015-05-04
—
—
Wunderlich
Reiterated · Buy · 2014-10-01
—
—
Imperial Capital
Reiterated · In Line · 2013-12-31
—
—
Benchmark
Reiterated · Buy · 2012-06-22
—
—
SunTrust Robinson Humphrey
Reiterated · Neutral · 2012-05-17
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space